Trial Profile
Renal cancer vaccine in patients with advanced renal cell carcinoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 13 Mar 2012
Price :
$35
*
At a glance
- Drugs Renal cancer vaccine (Primary) ; Renal cancer vaccine (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 13 Mar 2012 New trial record